Triumeq
RxNorm concept 1546889, brand name (bn).
- RxCUI
- 1546889
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1546889 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- abacavir sulfate (PIN, has precise ingredient)
- dolutegravir sodium (PIN, has precise ingredient)
- abacavir 600 MG / dolutegravir 50 MG / lamivudine 300 MG [Triumeq] (SBDC, ingredient of)
- abacavir / dolutegravir / lamivudine Oral Tablet [Triumeq] (SBDF, ingredient of)
- Triumeq Oral Product (SBDG, ingredient of)
- Triumeq Pill (SBDG, ingredient of)
- abacavir 600 MG / dolutegravir 50 MG / lamivudine 300 MG Oral Tablet [Triumeq] (SBD, ingredient of)
- abacavir 60 MG / dolutegravir 5 MG / lamivudine 30 MG [Triumeq] (SBDC, ingredient of)
- Triumeq Oral Liquid Product (SBDG, ingredient of)
- abacavir / dolutegravir / lamivudine Tablet for Oral Suspension [Triumeq] (SBDF, ingredient of)
- abacavir 60 MG / dolutegravir 5 MG / lamivudine 30 MG Tablet for Oral Suspension [Triumeq] (SBD, ingredient of)
- lamivudine (IN, tradename of)
- abacavir (IN, tradename of)
- dolutegravir (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1546889 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1546889 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1546889. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.